Can Brain Stimulation (tDCS) Help You Quit Smoking?
24 Oct 2026
A new systematic review of 21 studies found that tDCS, a gentle form of brain stimulation, slightly reduced nicotine craving and cigarettes smoked, but only for about a day after a session [1]. The evidence is still early and the certainty is low to moderate. It is not a replacement for proven quit-smoking support, though it may become a useful add-on.
Can Brain Stimulation (tDCS) Help You Quit Smoking at a glance
- What it is: tDCS passes a weak electrical current through scalp electrodes, usually over the front of the brain [2,3].
- What the review found: a small fall in craving and a moderate fall in smoking, both within the first day [1].
- How sure are we: moderate certainty for craving, low certainty for cigarettes smoked [1].
- What is missing: proof that it helps people stay off cigarettes for months [1,3].
- Safety: brain stimulation is generally well tolerated, with few dropouts from side effects in stroke trials [4].
What is tDCS, and why would it help with smoking?
Transcranial direct current stimulation (tDCS) uses two small electrodes on the scalp and a very low electrical current. It doesn't make nerve cells fire on its own. It only nudges how readily certain areas respond. In people who smoke regularly, the prefrontal cortex, which helps with self-control, tends to be less active, while the insula, which is linked to cravings, can be overactive [2]. The idea was simple: a few sessions might shift that balance and make cravings easier to ride out.
Sessions are short. In the two trials below, people had about 20 minutes of stimulation at each of five visits [2,3].
What did the new review actually find?
Researchers pooled 21 studies comparing real tDCS with sham stimulation, where the device is switched on briefly and then turned off so you can't tell the difference [1]. For craving, they found a small drop (Hedges' g of -0.26) and rated the certainty as moderate. For the amount people smoked, the drop was larger (g of -0.48), but certainty was low [1].
Both effects were seen only within the first day after stimulation. The review could not say which electrode position works best, and it did not show that people stayed smoke-free over months [1].
Do the individual trials agree?
Broadly, yes, with caveats. A small randomised trial of 36 people with nicotine dependence, active tDCS plus a ten-minute brief quit-smoking intervention lowered craving across the five sessions. Quit rates, however, were no different from sham stimulation, and the follow-up was three months [3].
Another trial, from Brazil, followed 41 smokers. Five sessions of tDCS reduced craving and cigarette use only when it was paired with aerobic exercise, not on its own [2]. That is a very small study, so treat it as an idea to test, not a result to rely on.
How strong is this evidence?
It's early. Samples are small, protocols differ from study to study, and most measured craving rather than long-term quitting [1,2,3]. A small, short-lived drop in craving is useful information, but craving is only one part of why people return to cigarettes. Stress, habit, social settings, and the people around you matter just as much.
The review's own authors say larger studies are needed before tDCS can be called an effective smoking-cessation treatment [1].
Is tDCS safe?
A review of 55 trials of brain stimulation after stroke found that about 95% of people completed their treatment, and only around 1% dropped out because of side effects. The most common complaint was tingling at the electrode site [4]. Those were people recovering from stroke, not people trying to quit smoking, so the figures don't transfer exactly. Still, they give a sense of how these devices are usually tolerated.
It still needs a proper medical check first. Tell the clinician about any seizures, implants or scalp problems before stimulation.
| Question | What studies show | How firm is it |
|---|---|---|
| Does it reduce craving? | Small reduction in the first day after stimulation | Moderate certainty |
| Does it reduce cigarettes smoked? | Moderate reduction in the first day | Low certainty |
| Does it help people stay quit for months? | Not shown; a 3-month trial found no difference in quit rates | Not established |
| Best electrode position? | No clear answer | Unknown |
| Works better with exercise or counselling? | Hints from two small trials | Preliminary |
What the evidence says about tDCS and smoking, and what it does not [1,2,3].
What should you do if you want to quit today?
Don't wait for brain stimulation to be proven. Quitting sooner is better for your lungs and heart, and a doctor can go through quit-smoking medicines and counselling with you. Set a quit date, and plan for the moments when you most want a cigarette: after meals, with tea, during stress. Telling your family helps too, because quitting is much easier when the people at home are on your side.
If tDCS interests you, see it as something that may one day support these steps, not replace them [1,3].
When should you ask for help with nicotine dependence?
Ask for an assessment if you have tried to quit several times and relapsed, or if smoking is tied up with anxiety, low mood, or alcohol use. Dependence often travels with other conditions, and treating them together usually works better than treating each alone.
If you are in distress or having thoughts of harming yourself, call Tele-MANAS on 14416 (free, 24/7). In an emergency, call 112.
Getting help in Delhi
Brain Bridge Clinic in Safdarjung Enclave, New Delhi, offers structured assessment for nicotine and other substance dependence, with counselling and, where appropriate, neuromodulation such as tDCS. At your first visit, a clinician goes through your smoking history, past quit attempts, medical conditions and any low mood or anxiety, then explains which options suit you and which don't. Because the tDCS research is still early, we'd raise it only as a possible add-on and be plain about what isn't known. Book an assessment, and bring a family member if you'd like them involved.
Related pages: De Addiction, tDCS, De Addiction Rehab Programs.
Frequently asked questions
Can tDCS make me stop smoking?
Not on its own, as far as current evidence shows. A recent review found a small, short-lived drop in craving and smoking after sessions, but no clear proof that it helps people stay quit for months [1].
How many tDCS sessions were used in smoking studies?
Several trials used five sessions of about 20 minutes each, on alternate or consecutive days [2,3]. Protocols vary, and the best schedule is not settled [1].
Is tDCS painful?
It is usually not painful. The most common sensation is mild tingling under the electrodes [4].
Is tDCS better than nicotine replacement or quit-smoking medicines?
There is no evidence that it is. The studies compared tDCS with sham stimulation, not with established treatments [1,3].
Does exercise help tDCS work?
One small Brazilian trial found craving fell only when tDCS was combined with aerobic exercise [2]. This needs confirming in larger studies.
References
- Niap CPS, Ooi N, Ang HE, et al. Effects of transcranial direct current stimulation on nicotine use disorder: a systematic review and meta-analysis. Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco. 2026;28(11):1784-1796. doi:10.1093/ntr/ntag152. PMID 42384937.
- da Silva GA, Silva LC, Filho EMT, et al. Transcranial direct current stimulation associated with physical exercise can help smokers to quit smoking: a randomized controlled trial. Scientific reports. 2025;15(1):8623. doi:10.1038/s41598-025-85877-4. PMID 40074739.
- Palm U, Obergfell M, Rabenstein A, et al. Transcranial direct current stimulation combined with a brief intervention for smoking cessation: a randomized double-blind clinical trial. European archives of psychiatry and clinical neuroscience. 2024;274(4):1001-1011. doi:10.1007/s00406-023-01705-8. PMID 37955682.
- Sun J, Wang Z, Huang Y, et al. Completion rate and safety of non-invasive brain stimulation for upper limb dysfunction after stroke: a systematic review and network meta-analysis. Frontiers in neurology. 2026;17:1853609. doi:10.3389/fneur.2026.1853609. PMID 42780542.